Уноси

• Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial (2025-01)

  Jelena Petković-Dabić, Ivana Binić, Bojana Carić, Ljiljana Božić, Sanja Umičević-Šipka, Nataša Bednarčuk, Saša Dabić, Mirna Šitum, Snježana Popović-Pejičić, Miloš P. Stojiljković, Ranko Škrbić, Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial, Biomolecules, Jan, 2025

• Dejstvo semaglutida na inflamatorni odgovor i klinički tok psorijatičnih lezija kod pacijenata sa diabetes melitusom tipa 2 (2025)

• Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial (2025-01)

  Ј. Петковић-Дабић, И. Бинић, Б. Царић, Љ. Божић, С. Умичевић-Шипка, N. Bednarčuk, С. Дабић, М. Шитум, С. Поповић-Пејичић, М. Стојиљковић, Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial, Biomedicines, Vol. 15, No. 1, Jan, 2025